Alnylam Pharmaceuticals
ALNY
#443
Rank
A$79.15 B
Marketcap
A$599.17
Share price
1.00%
Change (1 day)
56.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company